Do you have a dispute with a business?
Make it public
ENTERPRISE THERAPEUTICS LTD
SUSSEX INNOVATION CENTRE SCIENCE PARK SQUARE, FALMER, BRIGHTON, BN1 9SBCompany Number: 09022750
Incorporation date: 02-May-2014
Status: Active
Entity type: Private Limited Company
SIC codes:
72110 Research and experimental development on biotechnology
SUMMARY
This company is 11.1 years old and is currently active. It is controlled by multiple entities. Retained earnings is negative (GBP -88.3 million), which means the company has aggregate losses since it's inception or it has paid more dividends than it can afford; given the company's age, this is a sign of serious financial problems. The company has 1 active officers (directors or partners) who are or were officers of 7 other companies. The company has no public disputes filed on the Business Disputes Register. There are no court cases involving the company that we are aware of.FINANCIALS (BETA)
Next accounts due: 30-Sep-2025Accounts Filed: FULL (31-Dec-2023)
P&L Financials:
Year end | Currency | Revenue | Operating profit | Interest Received | Interest Paid | Tax | Net Profit GBP |
---|---|---|---|---|---|---|---|
31-Dec-2024 | GBP | -7,584,264 | 368,596 | 756,527 | -7,215,668 | ||
31-Dec-2023 | GBP | -3,931,787 | 43,944 | 961,089 | -3,887,843 | ||
31-Dec-2021 | GBP | 1,225,413 | -4,191,175 | 1,386 | 1,328,615 | -4,189,789 | |
31-Dec-2020 | GBP | 1,077,612 | -5,892,234 | 28,966 | 2,719 | 1,921,500 | -5,863,268 |
31-Dec-2019 | GBP | -7,775,885 | 151,501 | 2,807 | 1,259,037 | -7,627,190 | |
31-Dec-2018 | GBP | 90,968 | 17,039 | 402 | -4,961,193 | ||
31-Dec-2017 | GBP | 83,168 | -3,941,813 | 15 | 1,437 | -2,328,637 |
Balance Sheet Financials:
Year end | Currency | Cash | Current Assets | Current Liabilities | Debt | Share Capital | Premium Reserve | Retained Earnings | Net Assets |
---|---|---|---|---|---|---|---|---|---|
31-Dec-2024 | GBP | 6,714,252 | 10,400,640 | 23,428,824 | 318 | 62,319,246 | -88,283,540 | ||
31-Dec-2023 | GBP | 1,501,571 | 2,949,273 | 8,732,509 | 477 | 93,478,869 | -143,816,565 | 17,298,960 | |
01-Jan-2023 | GBP | 159 | 31,159,623 | -1,878,477 | |||||
31-Dec-2021 | GBP | 1,637,365 | 3,220,540 | 435,394 | 318 | 62,319,246 | -58,480,350 | ||
31-Dec-2020 | GBP | 1,821,342 | 7,018,901 | 227,497 | 477 | 93,478,869 | -94,338,276 | 18,328,188 | |
01-Jan-2020 | GBP | 113 | 23,164,919 | 3,977,914 | |||||
31-Dec-2019 | GBP | 2,508,323 | 5,032,633 | 487,193 | 345 | 69,494,757 | -69,121,280 | 11,933,749 | |
31-Dec-2018 | GBP | 11,086,173 | 12,808,408 | 114 | 23,164,919 | -11,559,927 | 11,605,106 | ||
31-Dec-2017 | GBP | 1,181,768 | 2,149,403 | 51 | 8,305,187 | -6,598,734 | 1,706,504 |
VALUATION EVENTS (BETA)
Year end | Currency | % Equity | Sum raised | Pre-Money Valuation* | Post-Money Valuation* | Enterprise Value** |
---|---|---|---|---|---|---|
31-Dec-2024 | GBP | -50.00% | -31,159,782 | 93,479,346 | 62,319,564 | 73,791,544 |
31-Dec-2023 | GBP | 66.67% | 62,319,564 | 31,159,782 | 93,479,346 | 61,568,779 |
01-Jan-2023 | GBP | -100.00% | -31,159,782 | 62,319,564 | 31,159,782 | 45,920,991 |
31-Dec-2021 | GBP | -50.00% | -31,159,782 | 93,479,346 | 62,319,564 | 76,170,102 |
31-Dec-2020 | GBP | 76.31% | 70,314,314 | 21,828,345 | 92,142,659 | 56,074,831 |
01-Jan-2020 | GBP | -205.31% | -46,330,070 | 68,896,009 | 22,565,939 | 44,476,813 |
31-Dec-2019 | GBP | 66.96% | 46,330,069 | 22,864,190 | 69,194,259 | 39,231,976 |
31-Dec-2018 | GBP | 55.26% | 14,859,795 | 12,029,358 | 26,889,153 | 13,325,285 |
** Estimated based on average Cash and Debt levels during period
DISPUTES
No disputes filed on www.disputesregister.orgCOMPANY SECRETARY
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All apointments (active/resigned) |
---|---|---|---|---|---|---|
Active | Philip James BOYD | 15 Dec 2016 | 23 May 2025 | 1 - 0 |
DIRECTORS
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All appointments (active/resigned) |
Dissolved companies (rate) |
---|---|---|---|---|---|---|---|
Resigned | Bart DZIKOWSKI | 01 Jan 2020 | 20 May 2021 | None | Canadian | 1 - 2 | 0 (0.0%) |
Resigned | Johnathan Craig, Dr RICHARDSON | 10 Sep 2019 | 20 May 2021 | Investment Partner | British | 1 - 2 | 0 (0.0%) |
Resigned | Amit MUNSHI | 02 Apr 2019 | 20 May 2021 | Company Director | American,Swiss | 1 - 2 | 0 (0.0%) |
Resigned | Bobby G., Dr SONI | 06 Apr 2018 | 10 Sep 2019 | Investment Director | American | 0 - 4 | 0 (0.0%) |
Resigned | David MORRIS | 06 Apr 2018 | 01 Jan 2020 | Venture Partner, Novartis Venture Fund | American | 0 - 1 | 0 (0.0%) |
Resigned | Alexander Volker, Dr MAYWEG | 06 Apr 2018 | 20 May 2021 | Venture Partner | German | 1 - 2 | 0 (0.0%) |
Active | John William, Dr FORD | 03 Nov 2016 | Ceo | British | 4 - 4 | 1 (12.5%) | |
Resigned | Robbie, Dr WOODMAN | 05 May 2015 | 15 Feb 2018 | Director Of Healthcare Ventures | British | 1 - 5 | 1 (16.7%) |
Resigned | Peter Michael, Dr FINAN | 08 Dec 2014 | 20 May 2021 | Venture Investor | British | 12 - 7 | 4 (21.1%) |
Resigned | Elizabeth ROPER | 08 Dec 2014 | 02 Apr 2019 | Fund Manager | Irish | 4 - 2 | 0 (0.0%) |
Resigned | Clive, Dr MCCARTHY | 02 May 2014 | 08 Dec 2014 | Scientist | British | 1 - 1 | 0 (0.0%) |
Resigned | Martin, Dr GOSLING | 02 May 2014 | 06 Apr 2018 | Scientist | British | 0 - 1 | 0 (0.0%) |
Resigned | Henry, Dr DANAHAY | 02 May 2014 | 08 Dec 2014 | Scientist | British | 0 - 2 | 1 (50.0%) |
Resigned | John Mervyn David, Professor STOREY | 02 May 2014 | 08 Dec 2014 | Scientist | British | 0 - 2 | 0 (0.0%) |
Average tenure of active directors: 8.6 years
Average tenure of resigned directors: 2.4 years
Average active director Dissolution Rate: 12.5%
DIRECTOR APPOINTMENTS IN OTHER COMPANIES
Name
|
||
---|---|---|
ARIO PHARMA LIMITED (07391909) - Active | ✔ | |
ENTERPRISE THERAPEUTICS LTD (09022750) - Active | ✔ | |
GREYFORD CONSULTING LIMITED (09027093) - Active | ✔ | |
METRION BIOSCIENCES LTD (09669815) - Active | ✔ | |
NATRIUM THERAPEUTICS LIMITED (10203271) - Dissolved | ✔ | |
COMPLEMENT THERAPEUTICS LIMITED (12515463) - Active | ✔ | |
ENTERPRISE THERAPEUTICS HOLDINGS LIMITED (12868901) - Active | ✔ | |
TMEM16A LIMITED (12868907) - Active | ✔ |
SHAREHOLDERS (BETA)
Shareholder name | Share class | Shares at confirmation date | ||||
---|---|---|---|---|---|---|
2020-05-02 | 2019-05-02 | 2018-05-02 | 2017-05-02 | 2016-05-02 | ||
VERSANT VENTURE CAPITAL VI, L.P. | SERIES B | 3,600,667 23.6% | 2,348,261 20.4% | 2,348,261 20.5% | 0 0% | 0 0% |
NOVARTIS BIOVENTURES LTD | SERIES B | 2,258,782 14.8% | 1,473,119 12.8% | 1,473,119 12.9% | 0 0% | 0 0% |
TOUCHSTONE INNOVATIONS BUSINESSES LLP | SERIES A | 2,199,300 14.4% | 2,199,300 19.1% | 2,199,300 19.2% | 1,649,475 41.9% | 0 0% |
EPIDAREX CAPITAL II, LP | SERIES A | 2,199,300 14.4% | 2,199,300 19.1% | 0 0% | 0 0% | 0 0% |
FORBION CAPITAL FUND III COOPERATIEF U.A. | SERIES B | 1,837,143 12.0% | 1,198,137 10.4% | 1,198,137 10.5% | 0 0% | 0 0% |
TOUCHSTONE INNOVATIONS BUSINESSES LLP | SERIES B | 1,036,639 6.79% | 1,036,639 9.01% | 1,036,639 9.07% | 0 0% | 0 0% |
IP2IPO PORTFOLIO (GP) LIMITED A/C IP2IPOPLP | SERIES B | 552,874 3.62% | 0 0% | 0 0% | 0 0% | 0 0% |
EPIDAREX CAPITAL II, LP | SERIES B | 418,294 2.74% | 0 0% | 0 0% | 0 0% | 0 0% |
DR DAVID G MORRIS | ORDINARY | 252,631 1.65% | 0 0% | 0 0% | 0 0% | 0 0% |
JOHN FLATLEY | SERIES A | 221,416 1.45% | 221,416 1.93% | 221,416 1.94% | 221,416 5.63% | 0 0% |
CLIVE MCCARTHY | ORDINARY | 150,000 0.982% | 150,000 1.30% | 100,000 0.875% | 100,000 2.54% | 100,000 3.83% |
AMIT MUNSHI | ORDINARY | 126,315 0.827% | 0 0% | 0 0% | 0 0% | 0 0% |
JOHN MERVYN DAVID STOREY | ORDINARY | 100,000 0.655% | 100,000 0.870% | 100,000 0.875% | 100,000 2.54% | 100,000 3.83% |
MARTIN GOSLING | ORDINARY | 100,000 0.655% | 100,000 0.870% | 100,000 0.875% | 100,000 2.54% | 100,000 3.83% |
HENRY DANAHAY | ORDINARY | 100,000 0.655% | 100,000 0.870% | 100,000 0.875% | 100,000 2.54% | 100,000 3.83% |
PETER MICHAEL FINAN | ORDINARY | 52,637 0.345% | 52,637 0.458% | 52,637 0.461% | 0 0% | 0 0% |
PHILIP JAMES BOYD | ORDINARY | 15,792 0.103% | 15,792 0.137% | 15,792 0.138% | 0 0% | 0 0% |
THE UNIVERSITY OF SUSSEX | ORDINARY | 12,371 0.081% | 12,371 0.108% | 12,371 0.108% | 12,371 0.315% | 12,371 0.474% |
DR HOLLY CHARLTON | ORDINARY | 6,500 0.043% | 6,500 0.057% | 0 0% | 0 0% | 0 0% |
JANET MAAS | ORDINARY | 6,500 0.043% | 0 0% | 0 0% | 0 0% | 0 0% |
DR ROY FOX | ORDINARY | 6,500 0.043% | 6,500 0.057% | 0 0% | 0 0% | 0 0% |
EDDIE FRENCH | ORDINARY | 6,500 0.043% | 0 0% | 0 0% | 0 0% | 0 0% |
DR SARAH LILLEY | ORDINARY | 6,500 0.043% | 6,500 0.057% | 0 0% | 0 0% | 0 0% |
KEITH OWEN | ORDINARY | 6,500 0.043% | 0 0% | 0 0% | 0 0% | 0 0% |
EPIDAREX CAPITAL IL, LP | SERIES B | 0 0% | 272,800 2.37% | 0 0% | 0 0% | 0 0% |
EPIDAREX CAPITAL II LP | SERIES A | 0 0% | 0 0% | 2,199,300 19.2% | 1,649,475 41.9% | 0 0% |
EPIDAREX CAPITAL II LP | SERIES B | 0 0% | 0 0% | 272,800 2.39% | 0 0% | 0 0% |
IMPERIAL INNOVATIONS BUSINESSES LLP | SERIES A | 0 0% | 0 0% | 0 0% | 0 0% | 1,099,650 42.1% |
EPIDAREX CAPITAL IT LP | SERIES A | 0 0% | 0 0% | 0 0% | 0 0% | 1,099,650 42.1% |
SHAREHOLDINGS (BETA)
no shareholding data
CONTROLLED COMPANIES / CONTROLLING ENTITIES
Controlling entities above
ENTERPRISE THERAPEUTICS LTD
no controlled companies
LATE PAYMENTS REPORT
This company has not filed any late payment reports possibly because it is not considered \'Large\'.
COURT CASES
No Court Cases found
PATENTS
No Patents found
COMPETITORS
(Based on Sic code:
72110 Research and experimental development on biotechnology)
Company | Registered Address | Company Number | YE Date | Revenue GBP | Net Profit GBP | Other SIC codes |
---|---|---|---|---|---|---|
ILLUMINA CAMBRIDGE LIMITED | 19 GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND, CB21 6DF | 03625145 | 2017-12-31 | 2,114,848,000 | 422,140,000 | |
IQVIA LTD. | 3 FORBURY PLACE, 23 FORBURY ROAD, READING, UNITED KINGDOM, RG1 3JH | 03022416 | 2017-12-31 | 1,123,545,000 | 198,818,000 | |
AMGEN LIMITED | 216 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND, CB4 0WA | 02354269 | 2017-12-31 | 238,931,000 | 9,488,000 | |
GENOME RESEARCH LIMITED | WELLCOME SANGER INSTITUTE WELLCOME GENOME CAMPUS, HINXTON, SAFFRON WALDEN, ENGLAND, CB10 1SA | 02742969 | 2018-09-30 | 144,812,000 | 55,555,000 | |
COVANCE LABORATORIES LIMITED | OTLEY RD, HARROGATE, HG3 1PY | 01171833 | 2017-12-31 | 111,519,000 | 16,839,000 | |
ASTEX THERAPEUTICS LIMITED | 436 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0QA | 03751674 | 2018-12-31 | 72,199,766 | 28,006,138 | |
CELLTECH R&D LIMITED | 208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE | 01472269 | 2017-12-31 | 55,407,000 | -5,338,000 | |
QUOTIENT SCIENCES LIMITED | TRENT HOUSE MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NOTTINGHAM, NG11 6JS | 05221615 | 2018-03-31 | 43,379,000 | 7,170,000 | |
CENTRE FOR PROCESS INNOVATION LIMITED | WILTON CENTRE, WILTON, REDCAR, CLEVELAND, TS10 4RF | 05002194 | 2018-03-31 | 33,187,000 | 7,344,000 |
72190-Other research and experimental development on natural sciences and engineering 82990-Other business support service activities not elsewhere classified 85320-Technical and vocational secondary education |
EVOTEC (UK) LIMITED | 114 INNOVATION DRIVE, MILTON PARK, MILTON, ABINGDON, OXFORDSHIRE, OX14 4RZ | 02674265 | 2017-12-31 | 31,859,000 | 1,599,000 | |
ARC TRINOVA LIMITED | C/O QUOTIENT SCIENCES LIMITED TRENT HOUSE MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NOTTINGHAM, ENGLAND, NG11 6JS | 09767194 | 2017-12-31 | 8,422,519 | 0 | |
CROWN BIOSCIENCE UK LIMITED | BUILDING 14 DODGEFORD LANE, OSGATHORPE, LOUGHBOROUGH, LEICESTERSHIRE, LE12 9TE | 07109059 | 2017-12-31 | 2,819,775 | 0 | |
INDUSTRIAL MICROBIOLOGICAL SERVICES LIMITED | ODD FELLOWS HALL, 118B OXFORD ROAD, READING, RG1 7NG | 03264423 | 2018-01-31 | 1,005,784 | 0 | |
THE BIO NANO CENTRE UNLIMITED | 69 ONSLOW ROAD, ONSLOW ROAD, RICHMOND, ENGLAND, TW10 6QA | 06389520 | 2018-02-28 | 974,607 | 0 | |
TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED | 2 HINKSEY COURT, CHURCH WAY, OXFORD, ENGLAND, OX2 9SX | 09930195 | 2017-12-31 | 334,157 | 0 |
86900-Other human health activities |
NEXT CLINICAL RESEARCH ORGANISATION LIMITED | 47 THE RIDGEWAY, FRIERN BARNET, LONDON, ENGLAND, N11 3LG | 09418105 | 2018-12-31 | 282,733 | 0 | |
MEDEZRIN LTD. | 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ | 03340737 | 2018-03-31 | 170,000 | 0 | |
NEW DIAGNOSTICS LIMITED | KNOLE VIEW, SOUTH HILL, SOMERTON, SOMERSET, TA11 7JQ | 08672341 | 2019-03-31 | 104,307 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
CLINICAL PHASE DEVELOPMENT LTD | 38 CABERFEIGH CLOSE, REDHILL, ENGLAND, RH1 6BF | 07715640 | 2018-07-31 | 94,690 | 0 | |
SEE-THROUGH SCIENTIFIC LIMITED | HARWOOD HOUSE, 43 HARWOOD ROAD, LONDON, ENGLAND, SW6 4QP | 09410281 | 2017-12-31 | 76,514 | 0 | |
DIAGNODUS LTD | ST JOHN'S INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, ENGLAND, CB4 0WS | 07600875 | 2019-04-30 | 63,322 | 0 | |
FISHER STATISTICS CONSULTANCY LIMITED | 10 HEDGEHOG CRESCENT, EDINBURGH, SCOTLAND, EH17 8XP | SC385170 | 2018-09-30 | 54,959 | 0 |
72200-Research and experimental development on social sciences and humanities 85600-Educational support services |
SERNAT LIMITED | 173 BROADWAY, DIDCOT, ENGLAND, OX11 8RZ | 10372226 | 2017-09-30 | 51,815 | 0 |
72200-Research and experimental development on social sciences and humanities 86210-General medical practice activities |
COULSON BIOINFORMATICS LTD | EXCHANGE BUILDING, 66 CHURCH STREET, HARTLEPOOL, UNITED KINGDOM, TS24 7DN | 10904839 | 2018-08-31 | 48,628 | 0 | |
IHG PHARMACO LIMITED | 20-22 WENLOCK ROAD, LONDON, N1 7GU | 05606880 | 2018-03-31 | 43,960 | 0 | |
CALA PHARMA LIMITED | 5 FARRIERS WAY, WINSFORD, ENGLAND, CW7 2TS | 09883439 | 2017-11-30 | 35,084 | 0 | |
GOLGENE TECHNOLOGIES LIMITED | 9 CHURCH LANE, BISHOPSTON, SWANSEA, WALES, SA3 3JT | 06069931 | 2019-01-31 | 35,041 | 0 | |
GREENSTONE BIOLABS LTD | 024, WESTBOURNE STUDIOS, ACKLAM ROAD, LONDON, ENGLAND, W10 5JJ | 09874376 | 2017-11-30 | 33,043 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
APPLIED EXOMICS LTD | LEE LARCOMBE, 39 HOGSDEN LEYS, ST. NEOTS, CAMBRIDGESHIRE, PE19 6AD | 08251827 | 2018-10-14 | 15,705 | 0 | |
SP SCIENTIFIC SERVICES LTD | 52 ANGEL HILL, SUTTON, UNITED KINGDOM, SM1 3EW | 10312528 | 2018-08-31 | 15,229 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
CHEMOVATION LIMITED | WA10 1GH, 49 ARRIVATO PLAZA, HALL STREET, ST HELENS, UNITED KINGDOM, WA10 1GH | 05316858 | 2018-12-31 | 12,182 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
AXONICS MODULATION TECHNOLOGIES, U.K. LIMITED | BREAKSPEAR PARK, BREAKSPEAR WAY, HEMEL HEMPSTEAD, HERTFORDSHIRE, ENGLAND, HP2 4TZ | 09622653 | 2019-06-30 | 8,610 | 0 | |
RIOTECH PHARMACEUTICALS LIMITED | 49 ARRIVATO PLAZA,, HALL STREET, ST HELENS, UNITED KINGDOM, WA10 1GH | 04316377 | 2018-11-30 | 8,428 | 0 | |
GENOMEX LTD | 129C LIME WALK, HEADINGTON, OXFORD, ENGLAND, OX3 7AD | 10356872 | 2018-09-30 | 7,923 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
ALLERAYDE SAB LIMITED | 1 MEADOW ROAD, NEWARK, NG24 3BP | 07909304 | 2019-01-31 | 4,348 | 0 | |
BIOMEMS TECHNOLOGIES LIMITED | 272 THE HAWTHORNS, CARDIFF, WALES, CF23 7AN | 09360659 | 2018-12-31 | 3,000 | 0 | |
OXFORD MEDISTRESS LTD | FLAT 1, 69, ONSLOW ROAD, RICHMOND, SURREY, ENGLAND, TW10 6QA | 05470178 | 2017-06-30 | 2,589 | 0 |
86900-Other human health activities |
ALCHEMY PHARMATECH LIMITED | 9 WATCOMBE ROAD, WATLINGTON, ENGLAND, OX49 5QJ | 07912825 | 2017-03-31 | 1,981 | 0 | |
PHYTOFUTURES LTD | 323 GRAFTON ROAD, LONDON, ENGLAND, NW5 4BJ | 09412092 | 2019-01-31 | 637 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
ALBANY CLINICAL CONSULTING LIMITED | 7 NEW BROUGHTON, EDINBURGH, MIDLOTHIAN, UNITED KINGDOM, EH3 6PA | SC532187 | 2018-04-30 | 295 | 0 | |
DYAX LTD | 1 KINGDOM STREET, LONDON, ENGLAND, W2 6BD | 08965623 | 2017-12-31 | 0 | 0 |
99999-Dormant Company |
ACUBLATE LIMITED | ANGEL BUILDING, 407 ST. JOHN STREET, LONDON, EC1V 4AD | 07209117 | 2018-03-31 | 0 | 0 | |
ARWAIN YMLAEN LIMITED | THE OLD TOWN HALL, 71 CHRISTCHURCH ROAD, RINGWOOD, BH24 1DH | 06062248 | 2019-03-31 | 0 | 0 | |
CELL RESEARCH TECHNOLOGY LTD | 32 FRIENDSHIP ROAD, BRISTOL, BS4 2RN | 08192207 | 2018-08-31 | 0 | 0 | |
DE NOVO PHARMACEUTICALS LIMITED | GILMARDE HOUSE, 47 SOUTH BAR STREET, BANBURY, OXFORDSHIRE, ENGLAND, OX16 9AB | 03761178 | 2018-09-30 | 0 | 0 | |
FERTILITY INNOVATIONS LIMITED | COOMBE HOUSE, BRADFORD PEVERELL, DORCHESTER, DORSET, DT2 9SE | 07416896 | 2018-12-31 | 0 | 0 | |
GARSINGTON TECHNOLOGIES LIMITED | 4, THE GABLES, VALE OF HEALTH, HAMPSTEAD, LONDON, ENGLAND, NW3 1AY | 08782927 | 2018-11-30 | 0 | 0 | |
IOTA PHARMACEUTICALS LIMITED | ST JOHNS INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, CAMBRIDGESHIRE, CB4 0WS | 06279987 | 2018-06-30 | 0 | 0 | |
LIF NANO RX LTD | APARTMENT 16 SPRINGS COURT, FIELD CLOSE, COTTINGHAM, ENGLAND, HU16 5GX | 08551193 | 2018-05-31 | 0 | 0 | |
MARBLEAMBER LIMITED | 29 GLADSTONE STREET, HATHERN, LOUGHBOROUGH, LEICESTERSHIRE, LE12 5LE | 07121238 | 2019-03-31 | 0 | 0 | |
NANO-NOSE LIMITED | THE STABLES SHIPTON BRIDGE FARM, WIDDINGTON, SAFFRON WALDEN, ENGLAND, CB11 3SU | 11014188 | 2018-07-31 | 0 | 0 | |
PT VENTURES LIMITED | 1A TOWER ROAD, DARTFORD, ENGLAND, DA1 2HE | 09821026 | 2018-10-31 | 0 | 0 | |
W C LEE LIMITED | 94 HOWARD AVENUE, SLOUGH, BERKSHIRE, ENGLAND, SL2 1LA | 09508311 | 2018-03-31 | 0 | 0 | |
WALTERSTEAD LIMITED | ACADEMY HOUSE, SHEDDEN PARK ROAD, KELSO, ROXBURGHSHIRE, TD5 7AL | SC368318 | 2018-03-31 | 0 | 0 |
75000-Veterinary activities 82990-Other business support service activities not elsewhere classified |
RESPIRATORY CLINICAL TRIALS LIMITED | 1 TOWER HOUSE, TOWER CENTRE, HODDESDON, HERTFORDSHIRE, ENGLAND, EN11 8UR | 04063160 | 0000-00-00 | 0 | 0 |
LIQUIDATION RISK (BETA)
This company is Active. Statistically, Active companies have a low probability of being liquidated within a year.
Here are our probability predictions:
Basis | Liquidation within 3 months | Liquidation within 6 months | Liquidation within 12 months | Prediction confidence |
---|---|---|---|---|
ENTERPRISE THERAPEUTICS LTD | 1.3% | 2.3% | 3.9% | Medium |
Other companies Active in the same sector | 1.2% | 3.5% | 7.4% | Medium |
Expanded sample | 1.3% | 2.3% | 3.9% | Medium |
Age | 0.4% | 1.7% | 3.3% | Medium |
Company Type | 0.7% | 3.7% | 7.4% | Medium |
Accounts category | 0.7% | 2.2% | 3.8% | Medium |
Accounting Month | 0.6% | 2.4% | 5.5% | Medium |
Sic code count | 0.7% | 3.5% | 7.0% | Medium |